Prevention of recurrent fetal growth retardation in patients with circulating antiphospholipid antibodies and genetic thrombophilia

Prevention of recurrent fetal growth retardation in patients with circulating antiphospholipid antibodies and genetic thrombophilia

Aim: to evaluate the effectiveness of using low molecular weight heparin (LMWH) and low-dose acetylsalicylic acid (ASA) in preventing recurrence of early and late fetal growth retardation (FGR) in patients with antiphospholipid syndrome (APS) and/or genetic thrombophilia.Materials and Methods. A pro...

Full description

Bibliographic Details
Main Authors: E. A. Orudzhova, V. O. Bitsadze, M. V. Tretyakova, D. A. Doronicheva, F. Yakubova
Format: Article
Language:Russian
Published: IRBIS LLC 2022-05-01
Series:Акушерство, гинекология и репродукция
Subjects:
fetal growth retardation
fgr
prophylaxis
low molecular weight heparin
lmwh
acetylsalicylic acid
asa
thrombophilia
antiphospholipid antibodies
apa
antiphospholipid syndrome
aps
Online Access:https://www.gynecology.su/jour/article/view/1308

Internet

https://www.gynecology.su/jour/article/view/1308

Similar Items